Abstract:Objective To establish progestin-resistant models of human endometrial carcinoma xenografts,and explore the role of epidermal growth factor receptor(EGFR) signaling pathway in progestin resistance of human endometrial carcinoma xenografts.Methods Thirty-six nude mice were subcutaneously injected with human endometrial carcinoma progestin-sensitive Ishikawa cells(n=18) or progestin-insensitive Ishikawa-pLWERNL cells(n=18),and human endometrial carcinoma xenografts were formed.Then,both nude mice treated with Ishikawa cells and Ishikawa-pLWERNL cells were divided into three groups,respectively(n=6),and were managed with medroxyprogesterone acetate(MPA)(MPA group),gefitinib(gefitinib group) and normal saline(control group),respectively.After treatment,wet weight of xenografts was recorded,and the expression of EGFR,progesterone receptor B(PR-B),ERK1/2,p-ERK1/2,AKT and p-AKT protein in xenograft tissues was detected by Western blotting.Results In nude mice treated with Ishikawa cells,the wet weight of xenografts in MPA group and gefitinib group was 43.0% and 31.5% lower than that in control group,respectively(P0.05).In nude mice treated with Ishikawa-pLWERNL cells,the wet weight of xenografts in gefitinib group and MPA group was 35.7% and 2.9% lower than that in control group,respectively(P0.05 and P0.05).The expression of EGFR protein in xenograft tissues treated with Ishikawa-pLWERNL cells was significantly higher than that in xenograft tissues treated with Ishikawa cells(P0.05),while that was opposite for the expression of PR-B protein(P=0.000).In xenograft tissues treated with Ishikawa cells,the expression of PR-B protein in MPA group was significantly lower than that in control group(P0.01),while there was no significant difference between gefitinib group and control group(P0.05).In xenograft tissues treated with Ishikawa-pLWERNL cells,there was no significant difference in the expression of PR-B protein among groups(P0.05).In xenograft tissues treated with Ishikawa cells,the expression of p-ERK1/2 and p-AKT protein in gefitinib group was significantly lower than that in control group and MPA group(P0.05).In xenograft tissues treated with Ishikawa-pLWERNL cells,the expression of p-ERK1/2 and p-AKT protein in gefitinib group was significantly lower than that in control group(P0.05),and the expression of p-ERK1/2 and p-AKT protein in MPA group was significantly higher than that in control group(P0.01).Conclusion The over-expressed EGFR protein can downregulate the expression of PR-B protein in Ishikawa-pLWERNL xenografts,which results in insensitivity to MPA.Gefitinib,the EGFR tyrosine kinase inhibitors,can effectively inhibit the expression of p-ERK1/2 and p-AKT protein,especially in progestin-insensitive Ishikawa-pLWERNL xenografts.

Krüppel-like factor 12 decreases progestin sensitivity in endometrial cancer by inhibiting the progesterone receptor signaling pathway

Krüppel-like Factor 12 Negatively Regulates Human Endometrial Stromal Cell Decidualization

Dysregulation of Krüppel-like Factor 12 in the Development of Endometrial Cancer.

Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy

Transcription Factor Klf12 Negatively Regulates Estradiol Synthesis in Ovarian Granulosa Cells

Involvement of Cyclin B1 in Progesterone-Mediated Cell Growth Inhibition, G2/M Cell Cycle Arrest, and Apoptosis in Human Endometrial Cell

KLF12 Promotes the Proliferation of Breast Cancer Cells by Reducing the Transcription of P21 in a P53-Dependent and P53-Independent Manner

Follicular Fluid Progesterone Downregulated HPGD and COX2 in Granulosa Cells Via Suppressing NF-ĸB in Endometriosis

Overexpressed Epidermal Growth Factor Receptor (egfr)‐induced Progestin Insensitivity in Human Endometrial Carcinoma Cells by the EGFR/mitogen‐activated Protein Kinase Signaling Pathway

TRPS1 Regulates the Opposite Effect of Progesterone Via RANKL in Endometrial Carcinoma and Breast Carcinoma

Abstract B009: Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targets

KLF12 Transcriptionally Regulates PD‐L1 Expression in Non‐small Cell Lung Cancer

Over-expression EGFR reduced sensitivity of human endometrial carcinoma cells to progesterone

Krüppel-like factor 12 is a novel negative regulator of forkhead box O1 expression: a potential role in impaired decidualization

Thyroid Hormone Receptor Β Knockdown Reduces Suppression of Progestins by Activating the Mtor Pathway in Endometrial Cancer Cells

Mechanism of Progestin Resistance in Endometrial Precancer/Cancer Through Nrf2-Akr1c1 Pathway

Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling

Krüppel-like factor 12 regulates aging ovarian granulosa cell apoptosis by repressing SPHK1 transcription and sphingosine-1-phosphate (S1P) production

KLF12 Interacts with TRIM27 to affect Cisplatin Resistance and Cancer Metastasis in Esophageal Squamous Cell Carcinoma by regulating L1CAM Expression

Role of Epidermal Growth Factor Receptor Signaling Pathway in Progestin Resistance of Human Endometrial Carcinoma Xenografts

Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells.